Bisphosphonates and colon cancer: Reply

Bisphosphonates and colon cancer: Reply

Show other versions (1)

Bibliographic Details
Main Authors:	Pazianas, M, Abrahamsen, B, Eiken, P, Eastell, R, Russell, R
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Bisphosphonates and colon cancer: reply.
by: Pazianas, M, et al.
Published: (2013)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
by: Pazianas, M, et al.
Published: (2012)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
by: Abrahamsen, B, et al.
Published: (2013)

Esophageal and gastric cancer incidence and mortality in alendronate users.
by: Abrahamsen, B, et al.
Published: (2012)

The risk of oesophageal and gastric cancer incidence and mortality in alendronate users: National cohort study
by: Abrahamsen, B, et al.
Published: (2011)

Safety of bisphosphonates.
by: Pazianas, M, et al.
Published: (2011)

Eliminating the need for fasting with oral administration of bisphosphonates.
by: Pazianas, M, et al.
Published: (2013)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
by: Pazianas, M, et al.
Published: (2013)

Safety issues with bisphosphonate therapy for osteoporosis.
by: Suresh, E, et al.
Published: (2014)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
by: Pazianas, M, et al.
Published: (2014)

Potential therapeutic effects of oral bisphosphonates on the intestine.
by: Pazianas, M, et al.
Published: (2011)

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
by: Eiken, P, et al.
Published: (2017)

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment
by: Abrahamsen, B, et al.
Published: (2016)

Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
by: Prieto Alhambra, D, et al.
Published: (2016)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
by: Pazianas, M, et al.
Published: (2012)

Atrial fibrillation and the use of oral bisphosphonates.
by: Pazianas, M, et al.
Published: (2011)

Bisphosphonates and bone quality.
by: Pazianas, M, et al.
Published: (2014)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
by: Pazianas, M, et al.
Published: (2010)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: Reply to Yarom and Elad
by: Pazianas, M, et al.
Published: (2008)

Evaluating the antifracture efficacy of bisphosphonates.
by: Pazianas, M, et al.
Published: (2009)

Bisphosphonates and in vivo models of multiple myeloma - Reply
by: Shipman, C, et al.
Published: (2001)

Bisphosphonates 2006
by: Russell, R
Published: (2006)

Atrial fibrillation and bisphosphonate therapy.
by: Pazianas, M, et al.
Published: (2010)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
by: Pazianas, M, et al.
Published: (2010)

Bisphosphonates
by: Bishop, N, et al.
Published: (2013)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
by: Pazianas, M
Published: (2013)

Bisphosphonates: from bench to bedside.
by: Russell, R
Published: (2006)

Bisphosphonates: the first 40 years.
by: Russell, R
Published: (2011)

Bisphosphonates: mode of action and pharmacology.
by: Russell, R
Published: (2007)

FORTY YEARS OF BISPHOSPHONATES
by: Russell, G
Published: (2010)

Bisphosphonates. Are they all the same?
by: Russell, G
Published: (2004)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
by: Hawley, S, et al.
Published: (2014)

Bisphosphonates: Mechanisms of Action
by: Roelofs, A, et al.
Published: (2008)

Therapeutic options after bisphosphonates
by: Russell, G
Published: (2007)

Determinants of structure-function relationships among bisphosphonates
by: Russell, R
Published: (2007)

Mineral binding affinities of bisphosphonates.
by: Nancollas, G, et al.
Published: (2002)

Bisphosphonates--mechanisms of action in multiple myeloma.
by: Shipman, C, et al.
Published: (2000)

Denosumab and bisphosphonates: different mechanisms of action and effects.
by: Baron, R, et al.
Published: (2011)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
by: Pazianas, M, et al.
Published: (2008)

Differentiation of bisphosphonates based on their physical chemical properties
by: Phipps, R, et al.
Published: (2006)